Female Infertility. Female Infertility
Conditions
Interventions
Intervention 1: Intervention group: antagonist group: since the second day of the cycle all patients will receive 150 unit of Cinal F (cinagen-Iran) subcutaneously, all patients in this group will rec
Sponsors
Yasouj University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Infertile PCOS patients which are candidate for ART
Exclusion criteria
Exclusion criteria: History of endocrine disorder Severe endometriosis Azoospermia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy. Timepoint: Two weeks after positive Beta HCG test. Method of measurement: Fetal heart by sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Chemical pregnancy. Timepoint: Serum beta hCG > 50 IU/L two weeks after embryo transfer. Method of measurement: Laboratory test.;Implantation rate. Timepoint: 2 weeks following the positive ß hCG. Method of measurement: The percentage of intrauterine gestational sacs detected by sonography divided by transferred embryos.;Oocyte maturity rate. Timepoint: The day of oocyte retrieval. Method of measurement: The number of metaphase II (MII) oocytes divided by the number of oocytes retrieved.;Fertilization proportion. Timepoint: 16 hours after fertilization. Method of measurement: The number of 2-pronuclears (2PNs) divided by the number of oocytes retrieved.;Fertilization rate. Timepoint: 16 hours after fertilization. Method of measurement: The number of 2PNs divided by the total number of MII oocytes. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Eftekhar
Yazd University of Medical Sciences
Outcome results
None listed